Sagimet Biosciences (SGMT) Accumulated Expenses (2023 - 2024)
Historic Accumulated Expenses for Sagimet Biosciences (SGMT) over the last 2 years, with Q3 2024 value amounting to $2.8 million.
- Sagimet Biosciences' Accumulated Expenses fell 1294.7% to $2.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $2.8 million, marking a year-over-year decrease of 1294.7%. This contributed to the annual value of $5.4 million for FY2023, which is N/A changed from last year.
- Latest data reveals that Sagimet Biosciences reported Accumulated Expenses of $2.8 million as of Q3 2024, which was down 1294.7% from $3.6 million recorded in Q2 2024.
- In the past 5 years, Sagimet Biosciences' Accumulated Expenses registered a high of $5.4 million during Q4 2023, and its lowest value of $2.4 million during Q2 2023.